Pectus carinatum

Barrow Women’s Board reaches milestone of $100M raised through Barrow Grand Ball

Retrieved on: 
Friday, January 27, 2023

PHOENIX, Jan. 27, 2023 (GLOBE NEWSWIRE) -- PHOENIX, Ariz. (January 26, 2023) – The Women’s Board of Barrow Neurological Foundation netted over $7 million for Barrow Neurological Institute through the 2023 Barrow Grand Ball, reaching an unprecedented lifetime milestone of $100 million raised since their 1965 inaugural Ball.

Key Points: 
  • PHOENIX, Jan. 27, 2023 (GLOBE NEWSWIRE) -- PHOENIX, Ariz. (January 26, 2023) – The Women’s Board of Barrow Neurological Foundation netted over $7 million for Barrow Neurological Institute through the 2023 Barrow Grand Ball, reaching an unprecedented lifetime milestone of $100 million raised since their 1965 inaugural Ball.
  • “The magnitude of achieving the lifetime $100 million mark is laudable, given the first Barrow Grand Ball 58 years ago earned $26,000,” said 2023 Women’s Board Chairman Diane Might.
  • “Our Board is an accomplished, dynamic, and influential group of women dedicated to supporting Barrow Neurological Institute.
  • Each year, the Ball Co-Chairs choose a specific Barrow research project to which members’ donations are expressly designated.

Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers to Treat Rare and Debilitating Diseases

Retrieved on: 
Monday, November 28, 2022

By reaching the midbrain safely through novel routes, Bionaut Labs aims to develop solutions to treat the most debilitating conditions including Parkinsons disease and Huntington's disease, malignant glioma and hydrocephalus.

Key Points: 
  • By reaching the midbrain safely through novel routes, Bionaut Labs aims to develop solutions to treat the most debilitating conditions including Parkinsons disease and Huntington's disease, malignant glioma and hydrocephalus.
  • Funds will be used to advance clinical development of the companys lead programs against malignant glioma brain tumors and Dandy-Walker Syndrome (a rare pediatric neurological disorder).
  • Bionaut Labs remains committed to finding new ways to treat these devastating diseases, which are long overdue for a breakthrough.
  • We are extremely excited about the transformative potential Bionaut presents in treating debilitating neurological disorders, said Vinod Khosla, founder of Khosla Ventures.

CDAHK Chiropractors Pushes Healthy Feeding of Children

Retrieved on: 
Saturday, November 26, 2022

LOS ANGELES, Nov. 26, 2022 /PRNewswire/ -- A study in the journal BMJ Global Health found that mothers who were exposed to a lot of digital marketing were less likely to breastfeed their babies for the first six months of their lives and more likely to give them processed foods and sugary drinks.

Key Points: 
  • Chiropractors from the CDAHK say that for your baby's best growth, development, and health, you should only breastfeed him or her for the first six months of life.
  • He received the prestige Effective Outreach Partner Award for the contribution to breastfeeding by the United Nation Children Foundation (UNICEF).
  • The CDAHK's vision and actions always aim at forging business and educating the public about healthy feeding enduring meaning and value that will eventually shape an exceptional future.
  • This call to action is very important to protect children's health and their right to breast milk and natural, healthy, enough, and good food.

Chiropractic May Offer Relief From Complicated Chronic Headaches

Retrieved on: 
Monday, November 21, 2022

NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Chiropractors may reduce the number of monthly neck pain and headaches for people who have chronic and complicated type of history, four case studies (1-4) published in 2022 American Journal of Case Reports, found.

Key Points: 
  • The researchers from Chiropractic Doctors Association of Hong Kong (CDAHK) released their case studies on chronic headaches and neck pain.
  • Chiropractors provide long-term relief from chronic headaches, said Eric Chu, principal investigator of the studies and Chairman of Chiropractic Doctors Association of Hong Kong.
  • "Our recent studies(4-12) have also found that chiropractic may be effective for episodic neck pain and chronic headaches.
  • Treating chronic pain is a multidisciplinary approach, and chiropractic is one of best treatment options that should be considered," Chu said.

MRI Reveals Significant Brain Abnormalities Post-COVID

Retrieved on: 
Monday, November 21, 2022

For this study, researchers used susceptibility-weighted imaging to analyze the effects that COVID-19 has on the brain.

Key Points: 
  • For this study, researchers used susceptibility-weighted imaging to analyze the effects that COVID-19 has on the brain.
  • "Our study highlights this new aspect of the neurological effects of COVID-19 and reports significant abnormalities in COVID survivors."
  • The researchers also found a significant difference in the right ventral diencephalon region of the brain stem.
  • The researchers are conducting a longitudinal study on the same patient cohort to determine whether these brain abnormalities persist over a longer time frame.

Vanessa Gibson, MD is recognized by Continental Who's Who

Retrieved on: 
Tuesday, November 15, 2022

LYNBROOK, N.Y., Nov. 15, 2022 /PRNewswire/ -- Vanessa Gibson, MD, is being recognized by Continental Who's Who as a Trusted Surgeon for her outstanding career in Thoracic Surgery and in acknowledgment of her exemplary service with Long Island Thoracic Surgery PC.

Key Points: 
  • LYNBROOK, N.Y., Nov. 15, 2022 /PRNewswire/ -- Vanessa Gibson, MD, is being recognized by Continental Who's Who as a Trusted Surgeon for her outstanding career in Thoracic Surgery and in acknowledgment of her exemplary service with Long Island Thoracic Surgery PC.
  • As a Thoracic Surgery Specialist, Dr. Gibson provides personalized care to patients with chest and lung issues.
  • An active member of her field, Dr. Gibson is a member of the Society of Thoracic Surgeons.
  • As a testament to her professional excellence, Dr. Gibson was recognized as a CMS Stage 1 EHR in 2012.

Scientists Identify Hidden Factor That Help Pain after Fibromyalgia

Retrieved on: 
Monday, November 14, 2022

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Scientists have identified treating cervical spondylosis helps patients with fibromyalgia stand up and live again.

Key Points: 
  • NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Scientists have identified treating cervical spondylosis helps patients with fibromyalgia stand up and live again.
  • A woman presented with a chronic headache, severe neck pain, shoulder pain, and back pain lasting for 2 years after experiencing domestic violence.
  • The widespread pain in fibromyalgia can lead to confused thinking and a lack of awareness of cervical spondylosis.
  • According to the researchers, this suggests chiropractic treatment blocked noxious inputs coming from pain sources, corrected pain thresholds, and lowered excitability, thereby eradicating fibromyalgia symptoms.

American Shared Hospital Services Reports 18% Period-over-Period Increase in Third Quarter 2022 Revenue to $4.8 Million

Retrieved on: 
Thursday, November 10, 2022

SAN FRANCISCO, CA, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced financial results for the third quarter and nine months of fiscal 2022, ended September 30, 2022.

Key Points: 
  • The gross margin percentage expanded 470 basis points to 40.5% of revenue compared to 35.8% for the third quarter of 2021.
  • Operating income for the third quarter of 2022 was $448,000 compared to operating income of $186,000 in the third quarter of 2021, an increase of 140.9%.
  • Adjusted EBITDA, a non-GAAP financial measure, was $1,999,000 for the third quarter of 2022, compared to $1,562,000 for the third quarter of 2021, an increase of 28.0%.
  • Cash at September 30, 2022 was $11,664,000, an increase of $3,401,000 from the December 31, 2021 balance of $8,263,000.

TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions

Retrieved on: 
Wednesday, November 9, 2022

HOERSHOLM, Denmark, Nov. 9, 2022 /PRNewswire/ -- TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) technology for dermatology, today announced that the United States Patent and Trademark Office (USPTO) has granted a U.S. patent no. 11/491,351 regarding its key technologies. The U.S. patent and already granted patents in Europe and China therefore complete the first phase of securing intellectual property rights for TOOsonix's unique technology in the major jurisdictions.

Key Points: 
  • The patents define methods for non-invasive and real-time image-guided treatment of skin using therapeutic ultrasound.
  • The technology has been implemented in the company's first product TOOsonix System ONE-M, which is currently in the late phase of approvals for medical treatments.
  • Torsten Bove and Tomasz Zawada, Co-founders of TOOsonix state: "Having patents in our three main markets has always been an essential milestone for the company.
  • TOOsonix is a Danish company pioneering therapeutic ultrasound for dermatological indications with its unique and patented high-frequency focused ultrasound device.

TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions

Retrieved on: 
Wednesday, November 9, 2022

HOERSHOLM, Denmark, Nov. 9, 2022 /PRNewswire/ -- TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) technology for dermatology, today announced that the United States Patent and Trademark Office (USPTO) has granted a U.S. patent no. 11/491,351 regarding its key technologies. The U.S. patent and already granted patents in Europe and China therefore complete the first phase of securing intellectual property rights for TOOsonix's unique technology in the major jurisdictions.

Key Points: 
  • The patents define methods for non-invasive and real-time image-guided treatment of skin using therapeutic ultrasound.
  • The technology has been implemented in the company's first product TOOsonix System ONE-M, which is currently in the late phase of approvals for medical treatments.
  • Torsten Bove and Tomasz Zawada, Co-founders of TOOsonix state: "Having patents in our three main markets has always been an essential milestone for the company.
  • TOOsonix is a Danish company pioneering therapeutic ultrasound for dermatological indications with its unique and patented high-frequency focused ultrasound device.